Foot Osteomyelitis Caused by Multidrug- and Extensively Drug-Resistant Gram-Negative Bacteria
- PMID: 37266476
- PMCID: PMC10231173
- DOI: 10.26574/maedica.2023.18.1.19
Foot Osteomyelitis Caused by Multidrug- and Extensively Drug-Resistant Gram-Negative Bacteria
Abstract
There are scarce data regarding foot osteomyelitis (FO) caused by multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacteria (GNB). This study investigates the causative organisms, the diagnostic and therapeutic approach and the outcome of these infections. All patients with FO caused by MDR and/or XDR GNB who received treatment in the Department of osseous infectious diseases of the "Attikon" University Hospital of Athens, Greece, were recorded and evaluated during a six-year-period. Seventeen patients, of which 64.7% females, with a mean age of 54.06 years were studied. There were nine cases with diabetic (DFO), and 76.5% of patients reported previous use of antimicrobials. Pathogens were isolated from soft-tissue biopsies or intra-operative tissue samples (n=12) and/or affected bone samples (n=5). In most cases, E. coli and P. aeruginosa were isolated (each 29.4%), followed by P. mirabilis (11.7%), while polymicrobial infection was detected in nine patients (53%). Most cases were given antimicrobial monotherapy (88.2%) with a mean duration of 90.05 days, while surgery significantly promoted cure of the infection. Foot and DFO cases represent a challenging to treat disease, requiring a multidisciplinary approach. Surgical treatment remains the cornerstone of treatment, while it is of utmost importance to isolate the causative organisms. MDR and XDR GNB represent an emerging threat and more data are needed to better understand these infections.
Figures





Similar articles
-
Multidrug-resistant Gram-negative osteomyelitis: a 10-year study.G Chir. 2018 Sep-Oct;34(5):284-290. G Chir. 2018. PMID: 30444476
-
Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic joint infections: Role of surgery and impact of colistin administration.Int J Antimicrob Agents. 2019 Mar;53(3):294-301. doi: 10.1016/j.ijantimicag.2018.10.018. Epub 2018 Nov 3. Int J Antimicrob Agents. 2019. PMID: 30395988
-
Microbiological Pattern, Antimicrobial Resistance and Prevalence of MDR/XDR Organisms in Patients With Diabetic Foot Infection in an Indian Tertiary Care Hospital.Int J Low Extrem Wounds. 2023 Dec;22(4):695-703. doi: 10.1177/15347346211038090. Epub 2021 Aug 12. Int J Low Extrem Wounds. 2023. PMID: 34382450
-
Off-label use versus formal recommendations of conventional and novel antibiotics for the treatment of infections caused by multidrug-resistant bacteria.Int J Antimicrob Agents. 2023 May;61(5):106763. doi: 10.1016/j.ijantimicag.2023.106763. Epub 2023 Feb 18. Int J Antimicrob Agents. 2023. PMID: 36804370 Review.
-
Multidrug-Resistant and Virulent Organisms Trauma Infections: Trauma Infectious Disease Outcomes Study Initiative.Mil Med. 2022 May 4;187(Suppl 2):42-51. doi: 10.1093/milmed/usab131. Mil Med. 2022. PMID: 35512375 Free PMC article. Review.
References
-
- King CM, Castellucci-Garza FM, Lyon L, et al. Microorganisms Associated With Osteomyelitis of the Foot and Ankle. J Foot Ankle Surg. 2020;59:491–494. - PubMed
-
- Lindbloom BJ, James ER, McGarvey WC. Osteomyelitis of the foot and ankle: diagnosis, epidemi-ology, and treatment. Foot Ankle Clin. 2014;19:569–88. - PubMed
-
- Pitocco D, Spanu T, Di Leo M, et al. Diabetic foot infections: a comprehen-sive overview. Eur Rev Med Pharmacol Sci. 2019;23(2 Suppl):26–37. - PubMed
Publication types
LinkOut - more resources
Full Text Sources